Protocols
1 protocol(s) meet the specified criteria
Drug: Neratinib
Protocol No.TitleStatus
TBCRC-022A Phase II Trial of HKI-272 (Neratinib) and Capecitabine for Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer and Brain MetastasesOpen